0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Sulfanilamide and Related Compounds in General Practice

JAMA. 1941;117(19):1657. doi:10.1001/jama.1941.02820450081030.
Text Size: A A A
Published online

ABSTRACT

The importance of the sulfonamide drugs in modern therapeutics is reflected in the voluminous literature that has accumulated since the first report on sulfanilamide which appeared in 1936. The author of this volume states that he consulted over one thousand original articles, reviews and monographs in the preparation of the book. The first important textbook on the sulfanilamide drugs to appear was "Sulfanilamide Therapy of Bacterial Infections" by Mellon, Gross and Cooper. Shortly thereafter the authoritative textbook "Clinical Use of Sulfanilamide and Sulfapyridine and Allied Compounds" by Long and Bliss became available. Dr. Spink's volume comes in natural sequence to those previously published.

After disposing of historical considerations and general principles of therapy the author devotes a chapter each to neoprontosil, sulfanilamide, sulfapyridine and sulfathiazole. Ten chapters are given to specific problems in treatment. For example, chapters are devoted to treatment of pneumonia and its complications, treatment of staphylococcic infections,

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();